1912 related articles for article (PubMed ID: 29449364)
1. Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity.
Jia G; Hill MA; Sowers JR
Circ Res; 2018 Feb; 122(4):624-638. PubMed ID: 29449364
[TBL] [Abstract][Full Text] [Related]
2. Role of AMP-activated protein kinase on cardio-metabolic abnormalities in the development of diabetic cardiomyopathy: A molecular landscape.
Haye A; Ansari MA; Rahman SO; Shamsi Y; Ahmed D; Sharma M
Eur J Pharmacol; 2020 Dec; 888():173376. PubMed ID: 32810493
[TBL] [Abstract][Full Text] [Related]
3. An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy.
Palomer X; Salvadó L; Barroso E; Vázquez-Carrera M
Int J Cardiol; 2013 Oct; 168(4):3160-72. PubMed ID: 23932046
[TBL] [Abstract][Full Text] [Related]
4. An overview of the inflammatory signalling mechanisms in the myocardium underlying the development of diabetic cardiomyopathy.
Frati G; Schirone L; Chimenti I; Yee D; Biondi-Zoccai G; Volpe M; Sciarretta S
Cardiovasc Res; 2017 Mar; 113(4):378-388. PubMed ID: 28395009
[TBL] [Abstract][Full Text] [Related]
5. Endothelial Dysfunction and Diabetic Cardiomyopathy.
Wang M; Li Y; Li S; Lv J
Front Endocrinol (Lausanne); 2022; 13():851941. PubMed ID: 35464057
[TBL] [Abstract][Full Text] [Related]
6. Molecular and metabolic mechanisms of cardiac dysfunction in diabetes.
Mandavia CH; Aroor AR; Demarco VG; Sowers JR
Life Sci; 2013 Mar; 92(11):601-8. PubMed ID: 23147391
[TBL] [Abstract][Full Text] [Related]
7. Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy.
Jia G; DeMarco VG; Sowers JR
Nat Rev Endocrinol; 2016 Mar; 12(3):144-53. PubMed ID: 26678809
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoid 1 receptor promotes cardiac dysfunction, oxidative stress, inflammation, and fibrosis in diabetic cardiomyopathy.
Rajesh M; Bátkai S; Kechrid M; Mukhopadhyay P; Lee WS; Horváth B; Holovac E; Cinar R; Liaudet L; Mackie K; Haskó G; Pacher P
Diabetes; 2012 Mar; 61(3):716-27. PubMed ID: 22315315
[TBL] [Abstract][Full Text] [Related]
9. The diabetic cardiomyopathy.
Tarquini R; Lazzeri C; Pala L; Rotella CM; Gensini GF
Acta Diabetol; 2011 Sep; 48(3):173-81. PubMed ID: 20198391
[TBL] [Abstract][Full Text] [Related]
10. Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways.
Huynh K; Bernardo BC; McMullen JR; Ritchie RH
Pharmacol Ther; 2014 Jun; 142(3):375-415. PubMed ID: 24462787
[TBL] [Abstract][Full Text] [Related]
11. Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease.
Jia G; Whaley-Connell A; Sowers JR
Diabetologia; 2018 Jan; 61(1):21-28. PubMed ID: 28776083
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms of cardiac pathology in diabetes - Experimental insights.
Varma U; Koutsifeli P; Benson VL; Mellor KM; Delbridge LMD
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt B):1949-1959. PubMed ID: 29109032
[TBL] [Abstract][Full Text] [Related]
13. Role of Oxidative Stress in Metabolic and Subcellular Abnormalities in Diabetic Cardiomyopathy.
Dhalla NS; Shah AK; Tappia PS
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244448
[TBL] [Abstract][Full Text] [Related]
14. Oxymatrine and insulin resistance: Focusing on mechanistic intricacies involve in diabetes associated cardiomyopathy via SIRT1/AMPK and TGF-β signaling pathway.
Seksaria S; Mehan S; Dutta BJ; Gupta GD; Ganti SS; Singh A
J Biochem Mol Toxicol; 2023 May; 37(5):e23330. PubMed ID: 36890713
[TBL] [Abstract][Full Text] [Related]
15. Diabetic cardiomyopathy--fact or fiction?
Maisch B; Alter P; Pankuweit S
Herz; 2011 Mar; 36(2):102-15. PubMed ID: 21424347
[TBL] [Abstract][Full Text] [Related]
16. Effect of diabetes on alteration of metabolism in cardiac myocytes: therapeutic implications.
Kota SK; Kota SK; Jammula S; Panda S; Modi KD
Diabetes Technol Ther; 2011 Nov; 13(11):1155-60. PubMed ID: 21751873
[TBL] [Abstract][Full Text] [Related]
17. [Diabetic cardiomyopathy].
Huang YQ; Wang X; Kong W
Sheng Li Ke Xue Jin Zhan; 2010 Feb; 41(1):31-6. PubMed ID: 21417012
[TBL] [Abstract][Full Text] [Related]
18. Molecular Dysfunction and Phenotypic Derangement in Diabetic Cardiomyopathy.
Evangelista I; Nuti R; Picchioni T; Dotta F; Palazzuoli A
Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31269778
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of cardiac dysfunction in diabetic cardiomyopathy: molecular abnormalities and phenotypical variants.
Prandi FR; Evangelista I; Sergi D; Palazzuoli A; Romeo F
Heart Fail Rev; 2023 May; 28(3):597-606. PubMed ID: 35001338
[TBL] [Abstract][Full Text] [Related]
20. Smad3 Signaling Promotes Fibrosis While Preserving Cardiac and Aortic Geometry in Obese Diabetic Mice.
Biernacka A; Cavalera M; Wang J; Russo I; Shinde A; Kong P; Gonzalez-Quesada C; Rai V; Dobaczewski M; Lee DW; Wang XF; Frangogiannis NG
Circ Heart Fail; 2015 Jul; 8(4):788-98. PubMed ID: 25985794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
